HEMOPHILIA ASSOCIATION OF NEW YORK INC (EIN 135650955) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1958

Legal Domicile

Principal Officer

LINDA MUGFORD

Phone

2126825510

Tax Period

2023-07-01 to 2024-06-30

HEMOPHILIA ASSOCIATION OF NEW YORK INC, founded in 1958, is a community nonprofit in the Diseases & Disorders sector that reported $2.3M in total revenue in fiscal year 2023. Revenue surged 303% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.2M, a strong 51% operating margin.

Mission

FUND CURES FOR HEMOPHILIA AND RELATED CONDITIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,234,392

Program Service Revenue $0

Investment Income $60,894

Other Revenue $10,303

TOTAL REVENUE $2,305,589

Expense Breakdown

Grants Paid $242,609

Salaries & Benefits $476,189

Fundraising Expenses $48,125

Program Expenses $818,779

Other Expenses $402,659

TOTAL EXPENSES $1,121,457

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,305,589	$572,223	+3.0%
Expenses	$1,121,457	$1,013,221	+0.1%
Net Income	$1,184,132	$-440,998	-3.7%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$207,045

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARIAM VOUTSIS	CHAIRMAN OF THE BOARD	2.00	Officer Director	$0	$0	$0
EILEEN MARGOLIES	TRUSTEE	2.00	Director	$0	$0	$0
EDWARD G ROGOFF PHD	TRUSTEE	2.00	Director	$0	$0	$0
MARK K SVENNINGSON	TRUSTEE	2.00	Director	$0	$0	$0
JEFFREY ZACHARIA	TRUSTEE	2.00	Director	$0	$0	$0
JOHANNA BAQUERO	TRUSTEE	2.00	Director	$0	$0	$0
THEODORE BUNIN	TRUSTEE	2.00	Director	$0	$0	$0
BRIAN EGAN	TRUSTEE	2.00	Director	$0	$0	$0
ROBERT M GREER	TRUSTEE	2.00	Director	$0	$0	$0
MARK KOVARIK	TRUSTEE	2.00	Director	$0	$0	$0
JOSEPH MUGFORD	TRUSTEE	2.00	Director	$0	$0	$0
MAGGI PACK	TRUSTEE	2.00	Director	$0	$0	$0
AUREO C PINTO JR	TRUSTEE	2.00	Director	$0	$0	$0
CHRISTOPHER N TOUSSAINT	TRUSTEE	2.00	Director	$0	$0	$0
LINDA E MUGFORD	EXECUTIVE DIRECTOR	40.00	Officer	$169,781	$37,264	$207,045

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$2,305,589	$1,121,457	$4,596,219	$1,184,132
2023	$572,223	$1,013,221	$3,242,886	$-440,998
2022	$563,478	$1,016,115	$3,657,906	$-452,637
2021	$326,271	$774,702	$4,332,778	$-448,431
2020	$2,353,082	$794,961	$4,331,795	$1,558,121
2019	$435,037	$908,235	$2,847,140	$-473,198
2018	$457,870	$853,672	$3,366,104	$-395,802

HEMOPHILIA ASSOCIATION OF NEW YORK INC